BridgeMD
Compares treatment options for Obesity
Official title A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
ClinicalTrials.gov ID: NCT07639021
What this study is testing
What is NNC0662-0419?
NNC0662-0419 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for obesity.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female (sex assigned at birth, inclusive of all gender identities).
- Age 18 years or above at the time of signing the informed consent.
- Body mass index (BMI) greater than or equal to (≥) 30.0 kilogram per square meter (kg/m\^2) at screening.
- Participant must have a desire and be committed to lose at least 25 percentage (%) of their body weight from randomisation.
You likely can't join if
- Known or suspected hypersensitivity to study intervention(s) or related products.
- Treatment with any medication prescribed for the indication of obesity or weight management (e.g. glucagon-like-peptide-1 (GLP-1) receptor agonists...
- Glycated haemoglobin (HbA1c) ≥ 6.5% (48 Millimoles per mole [mmol/mol]) as measured by the central laboratory at screening.
- History of type 1 or type 2 diabetes mellitus.
The study team makes the final eligibility decision.
Where it's taking place
- Montgomery, Alabama, United States
- Costa Mesa, California, United States
- Los Angeles, California, United States
- Hollywood, Florida, United States
- Miramar, Florida, United States
- Ocoee, Florida, United States
- Chicago, Illinois, United States
- Indianapolis, Indiana, United States
- Louisville, Kentucky, United States
- Rockville, Maryland, United States
- City of Saint Peters, Missouri, United States
- Westfield, New York, United States
- Wilmington, North Carolina, United States
- Wadsworth, Ohio, United States
- Philadelphia, Pennsylvania, United States
- Cumberland, Rhode Island, United States
- Bristol, Tennessee, United States
- Kingsport, Tennessee, United States
- Nashville, Tennessee, United States
- Houston, Texas, United States
+ 4 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montgomery, Alabama, United States; Costa Mesa, California, United States; Los Angeles, California, United States; Hollywood, Florida, United States; Miramar, Florida, United States; Ocoee, Florida, United States and 18 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.